Reconsidering β-Blockers in HFpEF: An Urgent Priority
Circulation · 10.11.2026 · 154 (19) · 1877-1880
DOI: 10.1161/circulationaha.126.083111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Circulation, erschienen am 10.11.2026. Verfasst von Parag Goyal und 2 weiteren Autor:innen. Beteiligte Einrichtung: Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, New York, NY (P.G.). Die Arbeit nennt 10 Literaturangaben. Gefördert von: NIA NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Program for the Care and Study of the Aging Heart, Department of Medicine, Weill Cornell Medicine, New York, NY (P.G.).
- Department of Cardiology, Kaiser Permanente San Francisco, CA (A.P.A.).
- Division of Research, Kaiser Permanente Northern California, Pleasanton (A.P.A.).
- Lillehei Heart Institute, Department of Medicine, University of Minnesota College of Medicine, Minneapolis (M.M.).
ORCID-Profile: Parag Goyal, Andrew P Ambrosy, Markus Meyer
Förderung
- NIA NIH HHS
Zitieren
APA
Goyal, P., Ambrosy, A. P., & Meyer, M. (2026). Reconsidering β-Blockers in HFpEF: An Urgent Priority. Circulation, 154(19), 1877-1880. https://doi.org/10.1161/circulationaha.126.083111
Vancouver
Goyal P, Ambrosy AP, Meyer M. Reconsidering β-Blockers in HFpEF: An Urgent Priority. Circulation. 2026;154(19):1877-1880. doi:10.1161/circulationaha.126.083111
BibTeX
@article{Goyal2026,
author = {Goyal, Parag and Ambrosy, Andrew P and Meyer, Markus},
title = {Reconsidering β-Blockers in HFpEF: An Urgent Priority},
journal = {Circulation},
year = {2026},
volume = {154},
number = {19},
pages = {1877--1880},
doi = {10.1161/circulationaha.126.083111}
}
EUVIMED